MedTrace Logo

Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology

NCT06334003 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-11-25

No results posted yet for this study

Summary

The overall objective is to establish the first-of-its-kind longitudinal cohort of pregnant women, biological fathers/partners and offspring from pregnancies achieved by frozen embryo transfer (FET), fresh-embryo transfer (fresh ET) and naturally conceived (NC) to investigate maternal cardiometabolic profiles, fetal growth patterns and placental function during pregnancy as well as metabolic and endocrine health in the offspring. Additionally, the aim is to explore genetic and epigenetic patterns in placenta, fetus and parents. As secondary objectives, the investigator group will examine telomere length and minipuberty hormones in children born after FET, fresh-ET and NC.

Conditions

  • ART
  • IVF
  • Children, Only
  • Cardiovascular Disease Other

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Anja B. Pinborg, Prof., MD · Fertility Department, Rigshospitalet

  • Rikke B. Jensen, MD, Ass. prof · Dept. of Paediatric and Adolescent Medicine, Herlev Hospital

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-17
Primary Completion
2026-05-30
Completion
2027-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06334003 on ClinicalTrials.gov